CD44 and hepatocellular carcinoma: Rodríguez et al. [51] reported that combining this molecule with an adenovirus carrying the interleukin-12 gene decreased the transcription of the CSC markers CD133, CD90, CD47, EpCAM, CD44, and CD13 in an orthotopic HCC model.